News from metabolic solutions development company, llc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 19, 2013, 10:39 ET

Investigational Diabetes Drug May Also Have Future As Treatment for Parkinson's Disease

Metabolic Solutions Development Company, LLC (MSDC) announced today the presentation of new data showing an investigational drug being studied to...

Sep 09, 2013, 06:00 ET
Alzheimer's disease is "quite possibly, type-3 diabetes." Facts & figures on impact of Alzheimer's disease, snapshot of insulin resistance as causal link in both diabetes and AD, current treatment options and projected availability of MSDC-0160 in clinical trials.  (PRNewsFoto/Metabolic Solutions Development Company, LLC)

Metabolic Solutions Development Company presents Phase 2a clinical trial results at the 14th International Conference on Alzheimer's Drug Discovery

 Metabolic Solutions Development Company, LLC (MSDC) has announced that Jerry Colca, PhD, co-founder and chief scientific officer of MSDC,...

May 29, 2013, 12:42 ET

Metabolic Solutions Development Company announces publication of data describing potential for new drugs to maintain pancreatic beta-cells in treating diabetes

Metabolic Solutions Development Company, LLC (MSDC) announced today the publication of data in a recent issue of the scientific journal PLOS ONE...

May 15, 2013, 17:15 ET

Metabolic Solutions Development Company announces publication of data describing a new drug target for diabetes

Metabolic Solutions Development Company, LLC (MSDC) announced today the publication of data in the latest issue of the scientific journal PLOS ONE...

Feb 07, 2013, 09:00 ET

Metabolic Solutions Development Company Awarded Funding by The Michael J. Fox Foundation

Metabolic Solutions Development Company, LLC (MSDC) announced today that it has received an award from The Michael J. Fox Foundation for...

Jan 24, 2013, 15:11 ET

Metabolic Solutions Development Company announces publication of Phase 2b data in Clinical Pharmacology & Therapeutics

Metabolic Solutions Development Company, LLC (MSDC) announced today the publication of data from a Phase 2b study of the company's prototype...

Oct 02, 2012, 06:00 ET

Researchers present findings on new drug target for treatment of type 2 diabetes

Researchers at Metabolic Solutions Development Company, LLC (MSDC) have identified a mitochondrial target through which insulin sensitizers achieve...

Sep 07, 2012, 17:41 ET
Aug 29, 2012, 11:01 ET

Metabolic Solutions Development Company to present at the Benzon Symposium No. 58 on Adipose Tissue in Health and Disease

Researchers at Metabolic Solutions Development Company, LLC (MSDC) have identified a mitochondrial protein complex through which insulin...

Jun 09, 2012, 10:00 ET

Metabolic Solutions Development Company novel insulin sensitizer meets Phase 2b study endpoints and affirms new mechanism of action

Metabolic Solutions Development Company, LLC (MSDC) presented Phase 2b results for MSDC-0160 today at the 72nd Scientific Sessions of the American...

Jun 09, 2012, 10:00 ET

Metabolic Solutions Development Company Identifies New Drug Target for Treatment of Type 2 Diabetes

Researchers at Metabolic Solutions Development Company, LLC (MSDC) have identified a mitochondrial protein complex through which anti-diabetic...

May 29, 2012, 13:23 ET

New Research Suggests Novel Insulin Sensitizer Works Through a New Mechanism to Treat Root Cause of Type 2 Diabetes

A study published online in the Journal of Biological Chemistry (http://www.jbc.org/content/early/2012/05/23/jbc.M112.363960) showed a new...

Apr 12, 2012, 09:00 ET

Metabolic Solutions Development Company Adds Barbara Cannon to Science and Medical Advisory Board

Metabolic Solutions Development Company, LLC (MSDC) has appointed Barbara Cannon, PhD to its Science and Medical Advisory Board. Dr. Cannon is a...

Mar 12, 2012, 11:49 ET

Metabolic Solutions Development Company Presents Case Study: A New Approach to Insulin Sensitizers During Phacilitate-Metabolic Leaders Forum 2012

Metabolic Solutions Development Company, LLC (MSDC) is developing novel insulin sensitizers that exert their pharmacological effects through an as...

Oct 06, 2011, 12:14 ET

Metabolic Solutions Development Company Receives $1.1 Million NIH Grant to Further Investigate MSDC-0602 for the Treatment of Fatty Liver Disease

Metabolic Solutions Development Company, LLC (MSDC) announced today it has received a $1.1 million multi-year Small Business Technology Transfer...

Sep 13, 2011, 06:16 ET

Metabolic Solutions Development Company Presents New Brown Fat Research at the European Association for the Study of Diabetes

Metabolic Solutions Development Company, LLC (MSDC) presented results today demonstrating its novel insulin sensitizers, MSDC-0160 and MSDC-0602,...

Sep 08, 2011, 14:11 ET

Metabolic Solutions Development Company Reports Positive Top-Line Results From Phase 2a Study of Its Second Compound to Treat Type 2 Diabetes

Metabolic Solutions Development Company, LLC (MSDC) confirmed today the potential of MSDC-0602 to achieve significant glucose control in type 2...